Deutsch English Français

Contact

EP2555620

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2555620

EP2555620 - SOPHOROLIPID ANALOG COMPOSITIONS [Right-click to bookmark this link]
Status	The application has been refused Status updated on 28.07.2017 Database last updated on 01.02.2025
Most recent event Tooltip	28.07.2017	Refusal of application	published on 30.08.2017 [2017/35]
Applicant(s)	For all designated states Polytechnic Institute of New York University Six Metro Tech Center Brooklyn, NY 11201 / US
	[2013/07]
Inventor(s)	01 / GROSS, Richard, A. 16 Northern Parkway East Plainview, New York 11803 / US
	02 / SCHOFIELD, Mark, H. 3728 Yuma Street NW Washington, DC 20016 / US
	[2013/07]
Representative(s)	Aulich, Martin, et al Meissner Bolte Patentanwälte Rechtsanwälte Partnerschaft mbB Hollerallee 73 28209 Bremen / DE
	[N/P]
Former [2013/07]	Aulich, Martin, et al Meissner, Bolte & Partner GbR Hollerallee 73 28209 Bremen / DE
Application number, filing date	11766614.9	05.04.2011
	WO2011US31310
Priority number, date	US201113080609	05.04.2011 Original published format: US201113080609
	US20100320885P	05.04.2010 Original published format: US 320885 P
	[2013/13]
Former [2013/07]	US20110080609	05.04.2011
	US20100320885P	05.04.2010
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2011127101
	Date:	13.10.2011
	Language:	EN
	[2011/41]
	Type:	A1 Application with search report
	No.:	EP2555620
	Date:	13.02.2013
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 13.10.2011 takes the place of the publication of the European patent application.
	[2013/07]
Search report(s)	International search report - published on:	US	13.10.2011
	(Supplementary) European search report - dispatched on:	EP	23.09.2013
Classification	IPC:	A01N43/04, A61K31/7048, A61P31/04, A61P31/10	[2013/42]
	CPC:	A01N25/30 (EP,US); C07H15/10 (US); A01N43/16 (EP,US); A01N43/90 (EP,US); A61K31/7028 (EP,US); A61K8/602 (EP,US); (+) A61P31/04 (EP); A61P31/10 (EP); A61Q19/00 (EP,US); C07H15/04 (US); C07H9/02 (US); A61K2800/10 (EP,US); A61Q17/005 (EP,US) (-)
	Former IPC [2013/07]	A01N43/04, A61K31/715
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/07]
Title	German:	SOPHOROLIPID-ANALOG-ZUSAMMENSETZUNGEN	[2013/07]
	English:	SOPHOROLIPID ANALOG COMPOSITIONS	[2013/07]
	French:	COMPOSITIONS D'ANALOGUES DE SOPHOROLIPIDES	[2013/07]
Entry into regional phase	25.10.2012	National basic fee paid
	25.10.2012	Search fee paid
	25.10.2012	Designation fee(s) paid
	25.10.2012	Examination fee paid
Examination procedure	25.10.2012	Examination requested [2013/07]
	04.06.2014	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
	12.08.2014	Amendment by applicant (claims and/or description)
	25.02.2015	Despatch of a communication from the examining division (Time limit: M06)
	07.09.2015	Reply to a communication from the examining division
	07.02.2017	Date of oral proceedings
	17.02.2017	Despatch of communication that the application is refused, reason: substantive examination [2017/35]
	17.02.2017	Minutes of oral proceedings despatched
	23.06.2017	Application refused, date of legal effect [2017/35]
Appeal following examination	27.04.2017	Appeal received No. T1495/17
	23.06.2017	Result of appeal procedure: appeal of the applicant withdrawn
Divisional application(s)	EP17168429.3 Application deemed to be withdrawn : 30.05.2017
	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 25.02.2015
Request for further processing for:	The application is deemed to be withdrawn due to failure to indicate the wish to proceed further with the application
	12.08.2014	Request for further processing filed
	12.08.2014	Full payment received (date of receipt of payment) Request granted
	26.08.2014	Decision despatched
	The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
	12.08.2014	Request for further processing filed
	12.08.2014	Full payment received (date of receipt of payment) Request granted
	26.08.2014	Decision despatched
Fees paid	Renewal fee
	12.04.2013	Renewal fee patent year 03
	31.03.2014	Renewal fee patent year 04
	27.04.2015	Renewal fee patent year 05
	25.04.2016	Renewal fee patent year 06
	27.04.2017	Renewal fee patent year 07
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[I]JPH06100581 (AGENCY IND SCIENCE TECHN) [I] 1-6 * paragraph [0012] *;
		[I]WO2004044216 (UNIV POLYTECHNIC [US], et al) [I] 1-6 * table 1; compounds natural mixture SL, lactonic SL *;
		[I]WO2004108063 (LVMH RECH [FR], et al) [I] 1-6 * claims 1-29; compound Formula I *;
		[I]WO2005089522 (GROSS RICHARD A [US], et al) [I] 1-6 * 17-L-[(2'-O-beta-D- glucopyranosyl-beta-D-glucopyranosyl)-oxy]-cis-9-octadecenoate-6', 6"-diacetate.;; claims 13-21; tables 1-2 *;
		[I]WO2006069175 (UNIV POLYTECHNIC [US], et al) [I] 1-6 * claim 1; table 1 *;
		[I]WO2007130738 (UNIV POLYTECHNIC [US], et al) [I] 1-6 * table 1; compounds di-acetate lactonic *;
		[I]US2009186835 (GROSS RICHARD A [US], et al) [I] 1-6 * lactonic sophorolipid diacetate (LSD);; figure 3; claims 1-10 * * paragraphs [0020] , [0026] *;
		[I] - S. LANG ET AL., "Antimicrobial Effects of Biosurfactants", FAT. SCI. TECHNOL., (1989), pages 363 - 366, XP002712199 [I] 1-6 * figure 1; tables 1,3 * DOI: http://dx.doi.org/10.1002/lipi.19890910908
		[I] - KIM K ET AL, "Characteristics of sophorolipid as an antimicrobial agent", JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, KOREAN SOCIETY FOR APPLIED MICROBIOLOGY, SEOUL, KR, (20020101), vol. 12, no. 2, ISSN 1017-7825, pages 235 - 241, XP008119603 [I] 1-6 * Structure and antmicrobial activity; page 238, paragraph right - page 239, paragraph left *
		[I] - SUSUMU ITO ET AL, "Growth of yeasts on n-alkanes: inhibition by a lactonic sophorolipid produced by Torulopsis bombicola", AGRICULTURAL AND BIOLOGICAL CHEMISTRY, JAPAN SOC. FOR BIOSCIENCE, BIOTECHNOLOGY AND AGROCHEM, TOKYO, JP, (19800101), vol. 4, no. 9, ISSN 0002-1369, pages 2221 - 2223, XP009172195 [I] 1-6 * the whole document * DOI: http://dx.doi.org/10.1271/bbb1961.44.2221
		[I] - CHEN J ET AL, "Production, structure elucidation and anticancer properties of sophorolipid from Wickerhamiella domercqiae", ENZYME AND MICROBIAL TECHNOLOGY, STONEHAM, MA, US, vol. 39, no. 3, doi:10.1016/J.ENZMICTEC.2005.12.022, ISSN 0141-0229, (20060703), pages 501 - 506, (20060703), XP025095215 [I] 1-6 * 4. Discussion; page 503 - page 504; figure fig.5 * DOI: http://dx.doi.org/10.1016/j.enzmictec.2005.12.022
		[I] - HU YONGMEI ET AL, "Lipase-mediated deacetylation and oligomerization of lactonic sophorolipids", BIOTECHNOLOGY PROGRESS, AMERICAN INSTITUTE OF CHEMICAL ENGINEERS, US, vol. 19, no. 2, doi:10.1021/BP0201197, ISSN 8756-7938, (20030301), pages 303 - 311, (20030207), XP002636234 [I] 1-6 * figures 1-2 * DOI: http://dx.doi.org/10.1021/bp0201197
		[I] - Yongmei Hu ET AL, "Sophorolipid production from different lipid precursors observed with LC-MS", Enzyme and Microbial Technology, (20010101), pages 593 - 601, URL: http://ac.els-cdn.com/S0141022901004392/1-s2.0-S0141022901004392-main.pdf?_tid=f305c3f2-148e-11e3-b7a4-00000aab0f01&acdnat=1378209174_964dc1c9026bdfdcca9fc303aac9d1cc, (20130903), XP055077472 [I] 1-6 * figures 5-6 * DOI: http://dx.doi.org/10.1016/S0141-0229(01)00439-2
		[I] - ASMER H-J ET AL, "MICROBIAL PRODUCTION, STRUCTURE ELUCIDATION AND BIOCONVERSION OF SOPHOROSE LIPIDS", JOURNAL OF THE AMERICAN OIL CHEMISTS' SOCIETY, SPRINGER, DE, (19880901), vol. 65, no. 9, ISSN 0003-021X, pages 1460 - 1466, XP000566442 [I] 1-6 * figure 5 *
	International search	[X] - AZIM ET AL., "Biologically Active Amino Acid Conjugated Sophorolipids", BIOCONJUGATE CHEM., (2006), vol. 17, no. 6, pages 1523 - 1529, XP008160841 DOI: http://dx.doi.org/10.1021/bc060094n
		[Y] - WU ET AL., "Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells", PNAS, (2005), vol. 102, no. 5, pages 1351 - 1356, XP003008372 DOI: http://dx.doi.org/10.1073/pnas.0408696102

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p